Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells.
The chromosome banding pattern has been analyzed in clones of mouse myeloid leukemic cells that differ in their ability to be induced to differentiate by the protein inducer MGI (macrophage and granulocyte inducer). None of the clones had a completely normal diploid banding pattern. The clones studied were either MGI+ (that can be induced to form Fc and C3 rosettes), a stage in the differentiation of myeloid cells, or MGI- (that cannot be induced to form these rosettes). All six cultured clones of MGI- cells from myeloid leukemias independently produced in six separate animals showed a loss of a piece of one chromosome 2 and this abnormal chromosome was maintained in leukemias derived from the cultured cells. This loss was not found in MGI+ clones or lymphoid leukemias. Five MGI+ mutants, derived from an MGI- clone with a loss of a piece of one chromosome 2, one normal chromosome 12, and two translocated chromosomes 12, maintained the abnormal chromosome 2 but lost either the one normal or one of these translocated chromosome 12. These results indicate that chromosomes 2 and 12 carry genes that control the differentiation of myeloid leukemic cells and that inducibility by MGI is controlled by the balance between these genes. We suggest that these chromosomes also carry genes that control the malignancy of these cells.
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002875:Chromosomes / Q000648:ultrastructure; D002999:Clone Cells; D007104:Immune Adherence Reaction; D007621:Karyotyping; D007942:Leukemia, Experimental / Q000235:genetics / Q000473:pathology; D007945:Leukemia, Lymphoid / Q000235:genetics; D007951:Leukemia, Myeloid / Q000235:genetics* / Q000473:pathology; D009154:Mutation; D011506:Proteins / Q000494:pharmacology; D014178:Translocation, Genetic
D011506:Proteins
J Natl Cancer Inst. 1960 Jul;25:85-109
14427847
J Cell Physiol. 1965 Dec;66(3):319-24
5884359
Nature. 1973 Jun 1;243(5405):290-3
4126434
Int J Cancer. 1974 Jul 15;14(1):40-8
4142462
Aust J Exp Biol Med Sci. 1966 Jun;44(3):287-99
4164182
J Cell Physiol. 1969 Dec;74(3):223-34
4187945
J Hered. 1972 Mar-Apr;63(2):69-72
5031315
J Cell Sci. 1971 May;8(3):659-72
5087653
Nature. 1969 Jul 26;223(5204):363-8
5387828
Nat New Biol. 1973 Jun 20;243(129):247-50
4515180
J Exp Med. 1970 Oct 1;132(4):702-20
4101362
Harvey Lect. 1974;68:1-35
4375672
Nature. 1971 Jun 25;231(5304):511-4
4326228
Nature. 1970 Jan 10;225(5228):136-9
4311930
Int J Cancer. 1976 Jan 15;17(1):47-56
946170
Proc Natl Acad Sci U S A. 1973 Feb;70(2):343-6
4510279
Proc Natl Acad Sci U S A. 1974 Sep;71(9):3507-11
4530318
Proc Natl Acad Sci U S A. 1975 Apr;72(4):1397-400
165506
J Cell Sci. 1974 Jun;15(1):177-83
4407324
Nature. 1974 Dec 13;252(5484):610-2
4431526
Hereditas. 1975;79(2):161-98
806563
Proc Natl Acad Sci U S A. 1976 Jun;73(6):2004-7
1064870
J Immunol. 1976 Aug;117(2):580-6
950462
Proc Natl Acad Sci U S A. 1975 Apr;72(4):1515-7
1055422
Proc Natl Acad Sci U S A. 1975 Jan;72(1):152-6
1054491
J Cell Physiol. 1975 Dec;87(2):167-77
1061711
Nature. 1976 Jan 15;259(5539):127-9
1246350
J Cell Physiol. 1976 Jan;87(1):89-100
1245560
J Cell Physiol. 1975 Oct;86(2 Pt 1):221-30
1194362
J Natl Cancer Inst. 1975 Jan;54(1):157-62
1113299
Proc Natl Acad Sci U S A. 1970 Nov;67(3):1542-9
5274478
Proc Natl Acad Sci U S A. 1966 Aug;56(2):488-95
5229970
Exp Cell Res. 1966 Oct;43(3):553-63
5957746
Nature. 1972 May 5;237(5349):33-4
4113130